Covaxin supply to double by May : The Tribune India

Join Whatsapp Channel

Covaxin supply to double by May

Production to be raised to 2 cr doses a month

Covaxin supply to double by May

Reeling under a record Covid-19 daily surge that touched 2,17,353 cases today, the government said it would double the production of indigenous Covaxin by May, and increase it nearly seven-fold by August. - PTI file



Tribune News Service

New Delhi, April 16

Reeling under a record Covid-19 daily surge that touched 2,17,353 cases today, the government said it would double the production of indigenous Covaxin by May, and increase it nearly seven-fold by August.

Hoping to escalate vaccinations as tools to beat the severe disease while hospitals fill up, the Centre also said that Rs 65-crore grant would be extended to Bharat Biotech’s new Bengaluru facility. The government in a statement today said, “The current production capacity of the Bharat Biotech-ICMR jab Covaxin will be doubled by May-June and then increased nearly six to seven-fold by July and August. The production will be raised from 1 crore vaccine doses in April this year to 7 crore vaccine doses a month by July-August. It is expected to reach nearly 10 crore doses per month by September 2021.” Three public sectors companies have also been asked to augment vaccine supplies for domestic use.

Prakash Javadekar

Haffkine Biopharmaceutical Corporation, Mumbai, a Maharashtra Government enterprise which had earlier sought 12 months to reach production capacity of 20 million doses of Covaxin a month, has now been told by the Centre to compress its timeline to six months.

Indian Immunologicals Ltd, Hyderabad, and Bharat Immunologicals and Biologicals Limited, Bulandshahr, will also be supported to prepare for producing 10 to 15 million doses of Covaxin a month by August. The active Covid-19 cases today crossed 15 lakh to settle at 15,69,743, which is 10.98 per cent of all cases. India saw more than 2 lakh daily cases for the second consecutive day today.

Masks must till vax mitigates impact: ECDC

Non-pharmaceutical interventions, such as physical distancing, should be stringently continued until vaccinations can “fully mitigate” the impact of the spread of SARS-CoV-2 and its known variants, says European Centre for Disease Control (ECDC) Director Andrea Ammon. PTI

2.17 Lakh new cases

CICSE defers class X, XII examinations

Work-from-home for govt staff, staggered hrs

PIL in SC seeks vax for all above 18 yrs

Javadekar tests Covid positive


Top News

Salman Khan house firing case: Accused attempts suicide in lock-up, dies at hospital in Mumbai

Salman Khan house firing case: Accused attempts suicide in lock-up, dies at hospital in Mumbai

Deceased was accused of supplying weapons to shooters who op...

2 Delhi schools evacuated after they receive bomb threat

At least 100 schools receive bomb threats in Delhi NCR; found nothing after checks, say police

The schools are evacuated after local police are informed ab...

Plea in Supreme seeking expert panel to examine possible side effects, risk factors of Covishield vaccine

PIL in Supreme Court seeks directions to study possible side effects of Astrazeneca's Covishield vaccine

Astrazeneca has admitted before a court in UK that Covishiel...

Sidhu Moosewala murder case: Court frames charges against Lawrence Bishnoi, 26 others

Sidhu Moosewala murder case: Court frames charges against jailed gangster Lawrence Bishnoi, 26 others

Canada-based gangster Goldy Brar, prime accused in the case,...


Cities

View All